Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(CH)
ATC Code
L01EX09
Source
SWISSMEDIC
(
ARTG
)
OFEV is indicated in combination with docetaxel for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after failure of first line chemotherapy.,OFEV is indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF).,OFEV is also indicated for the treatment of other chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype.,OFEV is indicated for slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).